Vivos Therapeutics News - VVOS

Company Name	Stock Ticker Symbol	Market	Type
Vivos Therapeutics Inc	VVOS	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	-0.08	-3.02%	2.57	20:00:00

Open Price	Low Price	High Price	Close Price	Prev Close
2.57	2.5445	2.72	2.57	2.65

more quote information »

Recent News

Date	Time	Source	Heading
4/09/2024	07:30	GLOBE	Vivos Therapeutics’ Flagship CARE Oral Medical Devices..
3/28/2024	16:05	GLOBE	Vivos Therapeutics Reports Fourth Quarter and Full Year 2023..
3/28/2024	07:30	GLOBE	Vivos Therapeutics Schedules Release of Fourth Quarter and..
2/15/2024	08:55	EDGAR2	Form 8-K - Current report
2/15/2024	08:00	GLOBE	Vivos Therapeutics Announces Exercise of Warrants for..
2/14/2024	17:42	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2/06/2024	07:30	GLOBE	Vivos Therapeutics Highlights Significant Favorable Market..
1/08/2024	07:30	GLOBE	Vivos Therapeutics Sees Positive Preliminary Metrics..
12/11/2023	07:30	GLOBE	Vivos Therapeutics Presents Groundbreaking Event:..
12/04/2023	00:15	EDGAR2	Form EFFECT - Notice of Effectiveness
12/01/2023	16:12	EDGAR2	Form 424B1 - Prospectus [Rule 424(b)(1)]
11/30/2023	16:05	EDGAR2	Form 8-K - Current report
11/30/2023	16:03	EDGAR2	Form S-1/A - General form for registration of securities..
11/29/2023	07:30	GLOBE	Vivos Therapeutics Receives First Ever FDA 510(k) Clearance..
11/22/2023	16:46	EDGAR2	Form S-1 - General form for registration of securities under..
11/14/2023	16:05	GLOBE	Vivos Therapeutics Reports Third Quarter 2023 Financial..
11/09/2023	16:30	GLOBE	Vivos Therapeutics Schedules Release of Third Quarter 2023..
11/03/2023	17:00	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
11/02/2023	17:10	EDGAR2	Form 8-K - Current report
11/02/2023	17:00	GLOBE	Vivos Therapeutics Closes $4 Million Private Placement
10/31/2023	08:00	GLOBE	Vivos Therapeutics Announces Pricing of $4 Million Private..
10/27/2023	16:15	EDGAR2	Form 8-K - Current report
10/26/2023	07:30	GLOBE	Vivos Therapeutics Announces Reverse Stock Split
10/24/2023	07:30	GLOBE	Vivos Therapeutics Signs Nationwide Distribution Agreement..
10/11/2023	07:30	GLOBE	Vivos Therapeutics to Begin Clinical Trial at Stanford..
10/05/2023	07:30	GLOBE	Vivos Therapeutics Announces Strategic Collaboration in the..
10/04/2023	15:55	APS	Biotech Soars On New Agreements
10/04/2023	07:30	GLOBE	Vivos Therapeutics Executes Strategic Agreements with Ormco..
10/02/2023	07:30	GLOBE	New York Times Best-Selling Author James Nestor to Headline..
9/25/2023	09:00	EDGAR2	Form 8-K - Current report
9/21/2023	17:10	EDGAR2	Form 8-K - Current report
9/14/2023	16:38	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
9/06/2023	17:26	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
8/28/2023	09:00	EDGAR2	Form DEF 14A - Other definitive proxy statements
8/21/2023	09:00	EDGAR2	Form 8-K - Current report
8/16/2023	16:45	EDGAR2	Form PRE 14A - Other preliminary proxy statements
8/16/2023	16:30	EDGAR2	Form 8-K - Current report
8/16/2023	16:16	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/16/2023	16:05	GLOBE	Vivos Therapeutics Reports Second Quarter 2023 Financial..
8/16/2023	07:30	GLOBE	Vivos Therapeutics Reschedules Second Quarter 2023 Financial..
8/14/2023	17:06	GLOBE	Vivos Therapeutics to Reschedule Second Quarter 2023..
8/10/2023	20:31	GLOBE	Vivos Therapeutics Schedules Release of Second Quarter 2023..
6/08/2023	16:05	GLOBE	Vivos Therapeutics Reports First Quarter 2023 Financial..
6/06/2023	16:30	GLOBE	Vivos Therapeutics Schedules Release of First Quarter..
5/09/2023	07:30	GLOBE	Vivos Therapeutics Announces Additional Strategic..
5/01/2023	07:30	GLOBE	Clinical Study Shows 92% of Patients Report Resolution of..